Equity Overview
Price & Market Data
Price: $0.937
Daily Change: -$0.029 / 3.09%
Range: $0.937 - $0.959
Market Cap: $10,924,408
Volume: 1,256
Performance Metrics
1 Week: 47.64%
1 Month: 96.40%
3 Months: 48.84%
6 Months: -97.91%
1 Year: -99.18%
YTD: -97.51%
Company Details
Employees: 5
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California.